Univest
Univest
  • Markets
  • Advanced Enzyme Analyst Review 2027: Revenue Up 16%, Buyback Done and the Stock at 17 Times Earnings

    • November 18, 2026
    • Posted by: Ankit Jaiswal
    • Category: Market
    No Comments
    Advanced Enzyme Analyst Review 2027: Revenue Up 16%, Buyback Done and the Stock at 17 Times Earnings

    Advanced Enzyme Technologies grew Q2 FY27 revenue about 16% and profit about 14%, completed a ₹69.7 crore buyback and trades near 17 times earnings. No recent named brokerage target could be verified. We review results, segments, valuation and risks for 2027.

    read more